Skip to main content

Table 2 (abstract P067). Candida albicans’ antifungal resistance

From: 38th International Symposium on Intensive Care and Emergency Medicine

 

5-fluorocytosine

Amphotericin B

Fluconazole

Itraconazole

Voriconazole

Susceptible n(%)

47(92.1)

48(94.7)

46(90.2)

44(86.3)

48(94.7)

Intermediate n(%)

1(2.6)

0(0)

0(0)

0(0)

0(0)

Resistant n(%) n(%)

3(5.3)

3(5.3)

5(9.8)

7(13.7)

3(5.3)